The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Pamir Ozan since 2021.
This trader's CIK number is 1834681.
At the time of last reporting, Pamir Ozan was the Chief Financial Officer of Chromadex Corp.. (stock ticker symbol CDXC).
Also see all insider trading activities at Chromadex Corp..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | CDXC | 2,907 | $21,395 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | ATNF | 5,162 | $5,213 | 0 | $0 | 0 | $0 |
| 2021 | ATNF | 3,800 | $14,706 | 0 | $0 | 0 | $0 |
2. 180 Life Sciences Corp. (ATNF)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-11-22 | CDXC | Buy | 2,907 | 7.36 | 21,395 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-05-18 | ATNF | Buy | 5,162 | 1.01 | 5,213 |
| 2021-12-10 | ATNF | Buy | 3,800 | 3.87 | 14,706 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pamir Ozan (Chief Financial Officer of Chromadex Corp. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.